Literature DB >> 9743363

Inducible nitric oxide synthase is not required for long-term vaccine-based immunity against Toxoplasma gondii.

I A Khan1, T Matsuura, L H Kasper.   

Abstract

Induction of reactive nitrogen intermediates by IFN-gamma is presumed an important mechanism of host resistance against acute and chronic infection with Toxoplasma gondii. Although nitric oxide (NO) has been shown to be important in the control of parasite replication in vivo, the role of this molecule in vaccine-based immunity against T. gondii is unknown. Mice with a targeted disruption of inducible NO synthase (iNOS) were immunized with an avirulent temperature-sensitive strain of this parasite (ts-4). Both the parental C57BL/6 and the iNOS(-/-) mice survived infection with the ts-4 mutant. Oral challenge of the vaccinated mice with a lethal dose of cysts containing bradyzoites resulted in reduced parasite burden and increased survival compared with nonvaccinated control mice. Host immunity in the iNOS(-/-) mice, similar to that observed in the parental strain, appears dependent upon both IFN-gamma and CD8+ T cells. These findings suggest that although vaccine-based long-term immunity against T. gondii is dependent upon the induction of IFN-gamma, it does not rely upon the anti-microbial effect of NO.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9743363

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Innate immunity to Toxoplasma gondii infection.

Authors:  Felix Yarovinsky
Journal:  Nat Rev Immunol       Date:  2014-02       Impact factor: 53.106

2.  Granule-dependent killing of Toxoplasma gondii by CD8+ T cells.

Authors:  Y Nakano; H Hisaeda; T Sakai; M Zhang; Y Maekawa; T Zhang; M Nishitani; H Ishikawa; K Himeno
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

3.  Role of gamma interferon in cellular immune response against murine Encephalitozoon cuniculi infection.

Authors:  I A Khan; M Moretto
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  T lymphocytes from granulocyte colony-stimulating factor-/- mice produce large quantities of interferon-gamma in a chronic infection model.

Authors:  S I Mannering; Y Zhan; B Gilbertson; G J Lieschke; C Cheers
Journal:  Immunology       Date:  2000-09       Impact factor: 7.397

5.  Toxoplasmosis.

Authors:  Joseph D. Schwartzman
Journal:  Curr Infect Dis Rep       Date:  2001-02       Impact factor: 3.725

6.  Treatment with soluble interleukin-15Ralpha exacerbates intracellular parasitic infection by blocking the development of memory CD8+ T cell response.

Authors:  Imtiaz A Khan; Magali Moretto; Xiao-Qing Wei; Martha Williams; Joseph D Schwartzman; Foo Y Liew
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

7.  Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma.

Authors:  G T De Sanctis; J A MacLean; K Hamada; S Mehta; J A Scott; A Jiao; C N Yandava; L Kobzik; W W Wolyniec; A J Fabian; C S Venugopal; H Grasemann; P L Huang; J M Drazen
Journal:  J Exp Med       Date:  1999-05-17       Impact factor: 14.307

8.  Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii.

Authors:  G S Yap; A Sher
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

9.  Toxoplasma gondii superinfection and virulence during secondary infection correlate with the exact ROP5/ROP18 allelic combination.

Authors:  Kirk D C Jensen; Ana Camejo; Mariane B Melo; Cynthia Cordeiro; Lindsay Julien; Gijsbert M Grotenbreg; Eva-Maria Frickel; Hidde L Ploegh; Lucy Young; Jeroen P J Saeij
Journal:  mBio       Date:  2015-02-24       Impact factor: 7.867

10.  MAP kinase phosphatase-2 plays a key role in the control of infection with Toxoplasma gondii by modulating iNOS and arginase-1 activities in mice.

Authors:  Stuart Woods; Juliane Schroeder; Helen A McGachy; Robin Plevin; Craig W Roberts; James Alexander
Journal:  PLoS Pathog       Date:  2013-08-15       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.